Accessibility Menu
 
Co-Diagnostics logo

Co-Diagnostics

(NASDAQ) CODX

Current Price$1.69
Market Cap$5.91M
Since IPO (2017)-99%
5 Year-99%
1 Year-85%
1 Month-26%

Co-Diagnostics Financials at a Glance

Market Cap

$5.91M

Revenue (TTM)

$622.49K

Net Income (TTM)

$46.90M

EPS (TTM)

$-31.01

P/E Ratio

-0.05

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$1.69

Volume

98,573

Open

$1.69

Previous Close

$1.69

Daily Range

$1.63 - $1.75

52-Week Range

$1.35 - $46.50

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Co-Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

115

CEO

Dwight Howard Egan

Website

co-dx.com

Headquarters

Salt Lake City, UT 84109, US

CODX Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-75%

Net Income Margin

-112%

Return on Equity

-125%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.91M

Shares Outstanding

3.60M

Volume

98.57K

Short Interest

0.00%

Avg. Volume

2.50M

Financials (TTM)

Gross Profit

$400.11K

Operating Income

$31.28M

EBITDA

$30.18M

Operating Cash Flow

$29.14M

Capital Expenditure

$700.05K

Free Cash Flow

$29.84M

Cash & ST Invst.

$11.88M

Total Debt

$1.24M

Co-Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$263.92K

+76.7%

Gross Profit

$121.53K

+214.9%

Gross Margin

-19.95%

N/A

Market Cap

$5.91M

N/A

Market Cap/Employee

$44.76K

N/A

Employees

132

N/A

Net Income

$25.75M

-133.4%

EBITDA

$7.39M

+36.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.65M

-61.4%

Accounts Receivable

$190.38K

+43.6%

Inventory

$992.40K

-7.5%

Long Term Debt

$574.30K

-53.6%

Short Term Debt

$662.26K

-27.7%

Return on Assets

-1.90%

N/A

Return on Invested Capital

-1.49%

N/A

Free Cash Flow

$6.33M

+23.8%

Operating Cash Flow

$6.20M

+24.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TNONTenon Medical, Inc.
$0.81+3.99%
ALURAllurion Technologies Inc.
$0.80-1.23%
VVOSVivos Therapeutics, Inc.
$1.03+0.00%
SINTSintx Technologies, Inc.
$2.66+1.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.86-0.05%
INTCIntel
$65.27-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.93+0.00%
NVTSNavitas Semiconductor
$18.47+0.20%

Questions About CODX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.